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Both insulin and contraction stimulate glucose transport in gastrocnemius and extensor digitorum longus muscles. As
skeletal muscle. Insulin-stimulated glucose transport is expected, the insulin-stimulated glucose transport rate in each
decreased in obese humans and rats. The aims of this study of the three muscles was significantly slower (P < 0.05) in obese
were (1) to determine if contraction-stimulated glucose trans- rats when compared with lean animals. When expressed as fold
port was also compromised in skeletal muscle of genetically stimulation over basal, there was no significant difference in
obese insulin-resistant Zucker rats, and (2) to determine contraction-induced muscle glucose transport rates between
whether the additive effects of insulin and contraction lean -and obese animals. Insulin-+contraction-stimulation was
previously observed in muscle from lean subjects were evident additive in skeletal muscle of lean animals, but synergistic in
in muscle from the obese animals. To measure glucose trans- skeletal muscle of obese animals. Prior contraction increased
port, hindlimbs from lean and obese Zucker rats were perfused insulin responsiveness of glucose transport 2-5-fold in the obese
under basal, insulin-stimulated (0.1,uM), contraction- rats, but had no effect on insulin responsiveness in the lean
stimulated (electrical stimulation of the sciatic nerve) and controls. This contraction-induced improvement in insulin
combined insulin- + contraction-stimulated conditions. One responsiveness could be of clinical importance to obese subjects
hindlimb was stimulated to contract while the contralateral leg as a way to improve insulin-stimulated glucose uptake in resist-
served as an unstimulated control. 2-Deoxyglucose transport ant skeletal muscle.
rates were measured in the white gastrocnemius, red
INTRODUCTION in obese animals compared with lean littermates (Friedman et
al., 1990; Zarjevski et al., 1992). Second, receptor tyrosine kinase
The cause of the insulin resistance in obesity and non-insulin- activity is decreased in the muscle of the obese Zucker rat (Slieker
dependent diabetes mellitus (NIDDM) has been the topic of et al., 1990); and third, insulin binding to soleus muscle is
continuing research since it was realized that a primary source of decreased by 25-35 0./ in the obese Zucker rat (Crettaz et al.,
the hyperglycaemia in these individuals was a failure of their 1980), which is similar to the decreased insulin binding to muscle
peripheral tissues (skeletal muscle and fat) to take up glucose insulin receptors in obese humans (Caro et al., 1987).
in response to normal insulin levels. Since skeletal muscle is Previous research has suggested that glucose transport can be
responsible for nearly 90 00 of the glucose disposal following a stimulated via two separate pathways in mammalian skeletal
glucose load (DeFronzo et al., 1985), a defect in skeletal-muscle muscle. One pathway is activated by insulin, and the other by
glucose uptake would have a large impact on total-body glucose contractile activity (Nesher et al., 1985; Zorzano et al., 1986;
homoeostasis. Our laboratory and others have demonstrated Constable et al., 1988; Wallberg-Henriksson et al., 1988). It is
that the decreased glucose uptake seen in skeletal muscle of not known if the contraction-stimulated pathway is normal in
obese/and or NIDDM individuals is due to a decrease in glucose skeletal muscle of obese individuals or if, like the insulin-
transport (Dohm et al., 1988) rather than a defect in utilization stimulated pathway, it is also depressed. Therefore, the first aim
(Shulman et al., 1991). Alterations in insulin-receptor number of the present study was to determine if contraction-stimulated
and/or glucose-transporter protein do not account entirely for glucose transport in skeletal muscle of obese individuals was
the insulin resistance seen with obesity and/or NIDDM (Caro et comparable with that seen in lean subjects.
al., 1987; Horton et al., 1990; Pedersen et al., 1990; Handberg et The combined effects of insulin and contraction on glucose
al., 1990; Dohm et al., 1991; Betts et al, 1991; Friedman et al., uptake are additive in insulin-sensitive skeletal muscle (Nesher et
1992; Eriksson et al., 1992). The decreased insulin-stimulatwed al., 1985; Constable et al., 1988; Wallberg-Henriksson et al.,
glucose transport must therefore be due in part to a defect in 1988; Henriksen et al., 1990). This additivity has not been
insulin signalling. Impairments in both insulin-stimulated tyro- examined in a model of insulin resistance in obesity. Hence, the
sine kinase activity of the insulin receptor (Caro et al., 1987; second aim of the present study was to determine whether the
Arner et al., 1987; Obermaier-Kusser et al., 1989) and insulin- additive effects of insulin and contraction would be observed in
induced suppression of soluble protein phosphatase activity skeletal muscle of the obese Zucker rat.
(McGuire et al., 1991) have been documented for insulin-resistant In order to address the above two aims, perfused skeletal
humans. The obese Zucker rat was chosen as the insulin- muscle was examined under the following four conditions: (1)
resistant model for the present experiments, because it mimics basal, (2) insulin stimulation, (3) contraction stimulation, and (4)
human obesity and NIDDM in several regards. First, decreased combined insulin + contraction stimulation. Results indicate that
total glucose-transporter protein (plasma and microsomal the contraction-stimulated pathway, unlike the insulin pathway
membranes) cannot account for the insulin resistance observed for glucose transport, is not impaired in skeletal muscle of obese
Abbreviation used: NIDDM, non-insulin-dependent diabetes mellitus.
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rats. In addition, insulin- + contraction-stimulation produces a
synergistic glucose transport response in obese skeletal muscle,
rather than an additive one.
METHODS
Animals
Male obese Zucker rats (fa/fa) (12 weeks of age, 412+ 16.2 g)
and their lean littermates (Fal?) (279 + 10.0 g) were obtained
from Charles River Laboratories (Raleigh, NC, U.S.A.). Animals
were housed individually, maintained on a 12 h-light/ 12 h-dark
cycle (light from 06.00 to 18.00 h) and provided with food
(Purina rodent chow) and water ad libitum. Perfusion experiments
were performed after an overnight fast.
Hindquarter perfusion
Rates of glucose transport were determined in the perfused rat
hindlimb (Ruderman et al., 1971) by using 2-deoxy[3H]glucose, a
glucose analog that is transported and phosphorylated, but not
metabolized further. Half of the perfusions contained a maximal
concentration of insulin in the perfusate and the other half had
no insulin added. One limb of each hindquarter was electrically
stimulated via the sciatic nerve, while the contralateral leg served
as an unstimulated control. This protocol resulted in four
different treatments: (1) basal, (2) contraction, (3) insulin, and
(4) insulin + contraction.
Perfusion of the hemicorpus was performed when the rats
were approx. 12 weeks of age. The rats were anaesthetized
intraperitoneally with ketamine (9 mg/ 100 mg body wt.) and
xylazine (1 mg/100 g body wt.) after an overnight fast. The
perfusion system has been described previously (Dohm et al.,
1980). The perfusion media (40% BSA, 5.5 mM glucose, 33 %
washed bovine red blood cells and Krebs-Henseleit buffer) was
gassed with 02/C02 (19: 1). Flow rate was 18 ml/min and
chamber temperature was maintained at 37 'C. The first 50 ml of
perfusate coming from the animal was discarded and the re-
maining 100 ml was recirculated. Glucose was infused at a rate
sufficient to maintain glucose concentration in perfusion media
at 5.5 + 0.14 mM. Insulin, when appropriate, was present at a
maximal concentration of 0.1 ,uM. At the end of a 30 min pre-
perfusion period, radioactive label was added to the media at a
final concentration of 20 mM sorbitol containing 0.1 ,uCi
of [U-_4C]sorbitol and 0.2 uCi of 2-deoxy[3H]glucose (tracer
amount). After an additional 30 min perfusion, the soleus,
extensor digitorum longus and red and white gastrocnemius
muscles were quickly removed and prepared for measurement of
transport rate.
Electrical stimulation
During the surgical procedures, a piece of 3-0 silk suture was
tied to the achilles tendon of the leg to be stimulated, and the
sciatic nerve was isolated. The other end of the suture was
attached to a force-displacement transducer (Grass) which was
connected to a polygraph (Grass model 7D). During the initial
contractions, muscle length was adjusted to achieve the maximal
increase of tension during' the contractions. An electrode was
attached to the sciatic nerve, and electrical stimulation was
delivered by a Grass 88 stimulator. The muscles were stimulated
during the last 12 min of the pre-perfusion period for two 5 min
periods separated by a 1 min rest period. Stimulation consisted
of 2 ms trains delivered at a rate of 1 per s. Each train consisted
of repeated 10 V pulses of 0.1 ms duration delivered at 100 Hz.
Measurement of 2-deoxyglucose transport and glucose uptake
A weighed portion (50-100 mg) of each muscle excised from the
perfused hindlimb was finely minced and added to 0.5 ml of
distilled water in a 7 ml scintillation vial. After dispersion of the
muscle by sonication (Heat Systems Sonicator, microtip), 5 ml of
scintillation fluid (Ecolite+; ICN) was added to the vial and
samples were counted for radioactivity in a Beckman LS 5000TD
liquid-scintillation counter preset for simultaneous counting of
3H/14C.
2-Deoxy[3H]glucose and [14C]sorbitol radioactivity (d.p.m.)
were counted in perfusate samples taken at 5 min intervals. Glu-
cose concentration was determined in the same samples (Sigma
kit, glucose oxidase determination) and these glucose values were
used to determine specific radioactivity of 2-deoxy[3H]glucose,
since glucose was the carrier for the 2-deoxy[3H]glucose. Accumu-
lation of intramuscular 2-deoxy[3H]glucose was determined by
subtracting extracellular 2-deoxy[3H]glucose (determined from
the [14C]sorbitol space) from total muscle 2-deoxy[3H]glucose.
Statistical analysis
All data are expressed as means+S.E.M. Differences between
treatment groups were evaluated by using a three-way ANOVA
with repeated measures of the contraction factor. For statistically
significant interaction effects, Tukey post hoc tests were used to
determine the site of significance. P values < 0.05 were considered
statistically significant.
RESULTS
Table 1 shows the glucose transport (umol/h per g) data. The
four treatment conditions (basal, insulin, contraction and
insulin + contraction) are displayed for white gastrocnemius, red
gastrocnemius and extensor digitorum longus muscles. These
muscles were chosen because they represent muscle of dissimilar
fibre-type composition (Ariano et al., 1973), which has been
Table 1 Effect of electrical stimulation and insulin on rates of glucose
transport in selected skeletal muscle
Values are means+ S.E.M. of 9 muscles/group: *P < 0.05, significantly less than lean.
'Predicted + C' are values expected if strict additivity was observed.
Glucose transport (,umol/h per g)
Extensor
White Red digitorum
Treatment gastrocnemius gastrocnemius longus
Basal
Lean
Obese
Insulin
Lean
Obese
Contraction
Lean
Obese
Insulin +
contraction (I + C)
Lean
Obese
Predicted l+C
Lean
Obese
1.23 + 0.30 1.O0 + 0.15 1.52 + 0.27
0.82 + 0.06 0.96 + 0.04 1.05 + 0.07
5.14+ 1.05 19.93 ±1.42 21.14 +2.56
1.50 + 0.24* 4.80 + 0.70* 3.06 + 0.54*
7.52 + 1.82 1.71 + 0.50 7.02 + 1.28
2.59 + 0.71 * 1.32 + 0.34 4.82 +1.16
12.04 + 2.04 19.82 + 0.96 33.62 ± 3.22
5.79 + 1.51 * 9.28 + 2.66* 10.97 + 2.24*
20.64
5.16
26.64
6.83
11.43
3.27
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Figure 1 Stimulation (fold) of glucose transport above basal induced by
insulin, contractile activity, and the combination of the two
There were 9 muscles per group: *significantly different from comparable lean group
(P< 0.05). Abbreviation: EDL, extensor digitorum longus.
shown previously to differ in insulin binding (Bonen et al., 1986),
glucose transporters (Kern et al., 1990) and glucose transport
capacities (James et al., 1985; Kern et al., 1990). The stimulation
protocol used in the present study did not elicit an effect of
muscle contraction on glucose transport in the soleus, and
therefore the soleus will not be included in the current discussion.
Figure 1 summarizes the data from Table 1 as fold stimulation
above basal. Dividing the stimulated rate by basal rate decreases
variability due to minor differences in basal rates between lean
and obese muscle and between the different muscle fibre types.
As expected, maximal insulin stimulation was significantly less in
the insulin-resistant obese animals compared with lean controls
for each of the three muscles (Figure 1). However, the
contraction-stimulated fold increase over basal was not
significantly different between obese and lean animals. Whereas
the insulin-+contraction-stimulated fold increase in the obese
animals was significantly lower than for lean controls in the
extensor digitorum longus and red gastrocnemius, it was closer
to the control level than were the insulin-stimulated values in the
same muscles. Insulin- + contraction-stimulation in the obese-rat
white gastrocnemius muscle did not differ from the lean-rat
muscle.
The combined effect of insulin + contraction on glucose trans-
port was additive in the skeletal muscle of lean animals (Table 1).
The glucose transport rate for insulin +contraction in skeletal
muscle of the obese animals was 2-fold greater than expected if
straight additivity had been observed.
DISCUSSION
The present findings demonstrate that, although the insulin-
stimulated pathway for glucose uptake into the cell is abnormal
in obesity, the contraction-stimulated pathway functions nor-
mally. This conclusion is further strengthened by the finding that
the translocation defect observed with maximal insulin stimu-
lation in skeletal muscle of the obese Zucker rat (Horton et al.,
1990) is not present after high-intensity treadmill exercise (Betts
et al., 1991).
Insulin (Wardzala and Jeanrenaud, 1981; Klip et al., 1987) and
muscle contraction (Hirshman et al., 1988; Douen et al., 1989;
Fushiki et al., 1989) both increase glucose transport via the
recruitment/activation of the GLUT4 glucose-transporter
isoform (Douen et al., 1990; Henriksen et al., 1990; Horton et
al., 1990; Betts et al., 1991) to/at the cell membrane. Skeletal-
muscle expression of GLUT4 protein (Friedman et al., 1990;
Zarjevski et al., 1992) or mRNA (Zarjevski et al., 1992) does not
differ between lean and obese Zucker rats. The fact that
contraction (known to recruit the same transporter isoform as
insulin) stimulates glucose transport normally in the obese rats
indicates that these GLUT4 transporters are functional if prop-
erly signalled. These findings suggest that the insulin resistance
observed in skeletal muscle of obese and NIDDM patients
cannot be attributed to defects intrinsic to the GLUT4 glucose-
transporter protein. Rather, the decreased insulin-stimulated
glucose uptake in obese-rat skeletal muscle may be due to a
defect in the insulin signalling pathway which prevents optimal
recruitment and/or activation of the glucose-transporter protein.
Prior investigations have shown that the maximal effects of
insulin and contractions on glucose transport are additive in
mammalian skeletal muscle (Nesher et al., 1985; Constable et al.,
1988; Wallberg-Henriksson et al., 1988; Henriksen et al., 1990).
In the present investigation, we also demonstrate an additive
relationship of insulin+ contraction in lean-rat skeletal muscle.
However, in obese-rat skeletal muscle, the combined effect of
insulin + contraction had synergistic, rather than additive, effects.
We believe that this 'extra' transport rate (above additivity)
represents an improvement in insulin responsiveness. If the
contraction-stimulated transport rate is subtracted from the
insulin- + contraction-stimulated rate, the remaining transport
rate, that attributed to insulin, can be compared with the insulin-
stimulated transport rate measured in the absence of prior con-
traction. If insulin responsiveness is unaltered by prior contrac-
tion, then the two transport rate values should be similar
and produce a ratio close to 1. Skeletal muscle of lean rats had
a ratio close to 1 (white gastrocnemius 1.16, red gastrocnemius
0.96, extensor digitorum longus 1.35), but the insulin-stimulated
glucose transport rate after contraction was increased 2-5-fold in
the skeletal muscle of obese animals (white gastrocnemius 4.7,
red gastrocnemius 2.08, extensor digitorum longus 3.06). Our
data suggest that contraction may modify a defect present in the
insulin pathway of the resistant skeletal muscle, thereby allowing
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the insulin responsiveness of these muscles to approach more
closely the non-defective response of lean controls.
Our laboratory and others have shown that the insulin-
stimulated tyrosine kinase activity of the insulin receptor is
depressed in skeletal muscle of obese patients with and without
NIDDM (Caro et al., 1987; Arner et al., 1987; Obermaier-
Kusser et al., 1989). Additionally, it has been shown that insulin-
induced suppression of soluble protein phosphatase activity is
severely impaired in insulin-resistant humans (McGuire et al.,
1991). Both decreased tyrosine kinase activity and increased
phosphatase activity would be expected to decrease subsequent
tyrosine phosphorylation. In the context of our data, we suggest
that contractile activity may inhibit a protein phosphatase leading
to increased phosphorylation of a signalling peptide, which in the
phosphorylated form is responsible for stimulating translocation
and/or activation of GLUT4. If this phosphorylated signalling
peptide is a common intermediate to both the exercise and
insulin-stimulated pathways, then contractile activity (exercise)
may result in an attenuated inhibition of the associated protein
phosphatase in insulin-resistant muscle in such a way that
subsequent insulin signalling is amplified.
Support for the occurrence of a common step in the insulin-
and contraction- or hypoxia-stimulated pathways is provided by
studies showing that polymyxin B inhibits both insulin-
stimulated and contraction/hypoxia-stimulated glucose trans-
port (Henriksen et al., 1989; Young et al., 1991). In addition,
Cartee and Holloszy (1990) reported that submaximal hypoxia-
stimulated glucose transport was greatly amplified in muscles
studied 3 h after exercise. This increased stimulation by hypoxia
is similar to the increased insulin sensitivity seen after exercise
and suggests that exercise mediates its effect on a late step that is
common to both the insulin- and the hypoxia-stimulated path-
way. Additionally, a study in our laboratory found that the
absolute rate of submaximal contraction-stimulated glucose
transport (electrical stimulation of sciatic nerve in perfused
hindlimb) was significantly increased in the white gastrocnemius
muscle of previously exercised obese Zucker rats compared
with non-exercised controls (P. L. Dolan, unpublished work). It
appears that exercise was able to amplify previously submaximal
contraction-stimulated glucose transport, just as it did with the
submaximal hypoxia-stimulated glucose transport in the study
by Cartee and Holloszy (1990).
In summary, contractile activity stimulates glucose transport
normally in skeletal muscle of obese rats. In fact, contractile
activity partially restores insulin-responsiveness in skeletal
muscle of obese animals and may therefore improve glucose
homoeostasis in skeletal muscle of obese insulin-resistant
subjects.
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